CD180
CD180 antigen
Also known as: CD180_HUMAN, LY64, Ly78, RP105
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99467
- Gene
- CD180
- Ensembl
- ENSG00000134061
- Chromosome
- 5
- Canonical length
- 661 aa
- Protein class
- CD markers, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Plasma membrane,Mitotic spindle
OverviewNCBI Gene
CD180 is a cell surface molecule consisting of extracellular leucine-rich repeats (LRR) and a short cytoplasmic tail. The extracellular LRR is associated with a molecule called MD-1 and form the cell surface receptor complex, RP105/MD-1. It belongs to the family of pathogen receptors, Toll-like receptors (TLR). RP105/MD1, by working in concert with TLR4, controls B cell recognition and signaling of lipopolysaccharide (LPS), a membrane constituent of Gram-negative bacteria. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
661 residues, UniProt reviewed canonical sequence.
>Q99467|CD180
1 MAFDVSCFFW VVLFSAGCKV ITSWDQMCIE KEANKTYNCE NLGLSEIPDT LPNTTEFLEF
61 SFNFLPTIHN RTFSRLMNLT FLDLTRCQIN WIHEDTFQSH HQLSTLVLTG NPLIFMAETS
121 LNGPKSLKHL FLIQTGISNL EFIPVHNLEN LESLYLGSNH ISSIKFPKDF PARNLKVLDF
181 QNNAIHYISR EDMRSLEQAI NLSLNFNGNN VKGIELGAFD STIFQSLNFG GTPNLSVIFN
241 GLQNSTTQSL WLGTFEDIDD EDISSAMLKG LCEMSVESLN LQEHRFSDIS STTFQCFTQL
301 QELDLTATHL KGLPSGMKGL NLLKKLVLSV NHFDQLCQIS AANFPSLTHL YIRGNVKKLH
361 LGVGCLEKLG NLQTLDLSHN DIEASDCCSL QLKNLSHLQT LNLSHNEPLG LQSQAFKECP
421 QLELLDLAFT RLHINAPQSP FQNLHFLQVL NLTYCFLDTS NQHLLAGLPV LRHLNLKGNH
481 FQDGTITKTN LLQTVGSLEV LILSSCGLLS IDQQAFHSLG KMSHVDLSHN SLTCDSIDSL
541 SHLKGIYLNL AANSINIISP RLLPILSQQS TINLSHNPLD CTCSNIHFLT WYKENLHKLE
601 GSEETTCANP PSLRGVKLSD VKLSCGITAI GIFFLIVFLL LLAILLFFAV KYLLRWKYQH
661 ILocalizationUniProt · AlphaFold · HPA
Whether an antibody against CD180 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 22 nTPM
- lymph node: 22 nTPM
- spleen: 12 nTPM
- appendix: 9.2 nTPM
- breast: 6.3 nTPM
- small intestine: 3.7 nTPM
Single-cell type
- hofbauer cells: 150 nCPM
- breast lactating cells: 58 nCPM
- plasma cells: 50 nCPM
- b-cells: 48 nCPM
- kupffer cells: 35 nCPM
- monocyte progenitors: 33 nCPM
Immune cell
- naive B-cell: 79 nTPM
- memory B-cell: 77 nTPM
- non-classical monocyte: 35 nTPM
- plasmacytoid DC: 24 nTPM
- myeloid DC: 22 nTPM
- intermediate monocyte: 20 nTPM
Brain region
- white matter: 5.2 nTPM
- pons: 5.1 nTPM
- thalamus: 4.9 nTPM
- medulla oblongata: 4.3 nTPM
- midbrain: 3.5 nTPM
- cerebral cortex: 3.1 nTPM
ReferencesPubMed · IEDB
Publications for CD180 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
5 publications
- CD180 Ligation Inhibits TLR7- and TLR9-Mediated Activation of Macrophages and Dendritic Cells Through the Lyn-SHP-1/2 Axis in Murine Lupus.
2018 · Front Immunol · RCR 1.1 · 31 citations - Toll-Like Receptor Mediated Activation of Natural Autoantibody Producing B Cell Subpopulations in an Autoimmune Disease Model.
2019 · Int J Mol Sci · RCR 0.8 · 16 citations - Ligation of TLR Homologue CD180 of B Cells Activates the PI3K/Akt/mTOR Pathway in Systemic Sclerosis and Induces a Pathological Shift in the Expression of BAFF Receptors.
2022 · Int J Mol Sci · RCR 0.7 · 8 citations - Rewiring of sIgM-Mediated Intracellular Signaling through the CD180 Toll-like Receptor.
2015 · Mol Med · RCR 0.5 · 15 citations - Toll-like Receptor Homologue CD180 Ligation of B Cells Upregulates Type I IFN Signature in Diffuse Cutaneous Systemic Sclerosis.
2024 · Int J Mol Sci · RCR 0.3 · 2 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.99
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.19
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell proliferation
- B cell proliferation involved in immune response
- cellular response to lipopolysaccharide
- inflammatory response
- innate immune response
- positive regulation of lipopolysaccharide-mediated signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cysteine-rich flanking region, C-terminal
- Leucine-rich repeat
- Leucine-rich repeat, typical subtype
- Leucine-rich repeat domain superfamily
- Leucine rich repeat
- CD180, leucine-rich repeat
- Leucine-rich repeat
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CD180 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CD180 as an antibody target. Whether an autoantibody or antibody against CD180 could matter depends on whether native CD180 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CD180 is annotated at the cell surface, where native CD180 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CD180 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...